BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29574928)

  • 21. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
    Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
    Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.
    Cun J; Yang Q
    Biomed Pharmacother; 2018 Nov; 107():117-128. PubMed ID: 30086458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer.
    Tsuchida A; Ohno S; Wu W; Borjigin N; Fujita K; Aoki T; Ueda S; Takanashi M; Kuroda M
    Cancer Sci; 2011 Dec; 102(12):2264-71. PubMed ID: 21883694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.
    Li Y; Vecchiarelli-Federico LM; Li YJ; Egan SE; Spaner D; Hough MR; Ben-David Y
    Blood; 2012 May; 119(19):4486-98. PubMed ID: 22451425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-92a enhances recombinant protein productivity in CHO cells by increasing intracellular cholesterol levels.
    Loh WP; Yang Y; Lam KP
    Biotechnol J; 2017 Apr; 12(4):. PubMed ID: 28146316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation.
    He G; Zhang L; Li Q; Yang L
    Biomed Pharmacother; 2014 Feb; 68(1):25-30. PubMed ID: 24332650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The miR-17 ∼ 92a cluster of microRNAs is required for the fitness of Foxp3+ regulatory T cells.
    Skinner JP; Keown AA; Chong MM
    PLoS One; 2014; 9(2):e88997. PubMed ID: 24523948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of VHL tumor suppressor mRNA and miR-92a in papillary thyroid carcinoma and their correlation with clinical and pathological parameters.
    Todorović L; Stanojević B; Mandušić V; Petrović N; Živaljević V; Paunović I; Diklić A; Saenko V; Yamashita S
    Med Oncol; 2018 Jan; 35(2):17. PubMed ID: 29340905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-92a inhibits porcine ovarian granulosa cell apoptosis by targeting Smad7 gene.
    Liu J; Yao W; Yao Y; Du X; Zhou J; Ma B; Liu H; Li Q; Pan Z
    FEBS Lett; 2014 Nov; 588(23):4497-503. PubMed ID: 25448599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-92a regulates angiogenic activity of adipose-derived mesenchymal stromal cells.
    Kalinina N; Klink G; Glukhanyuk E; Lopatina T; Efimenko A; Akopyan Z; Tkachuk V
    Exp Cell Res; 2015 Nov; 339(1):61-6. PubMed ID: 26477824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-92a inhibits fibroblast-like synoviocyte proliferation and migration in rheumatoid arthritis by targeting AKT2.
    Yu FY; Xie CQ; Jiang CL; Sun JT; Feng HC; Li C; Huang XW
    J Biosci; 2018 Dec; 43(5):911-919. PubMed ID: 30541951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway.
    Ke TW; Wei PL; Yeh KT; Chen WT; Cheng YW
    Ann Surg Oncol; 2015 Aug; 22(8):2649-55. PubMed ID: 25515201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a miR-92a delivery system for anti-angiogenesis-based cancer therapy.
    Ando H; Okamoto A; Yokota M; Shimizu K; Asai T; Dewa T; Oku N
    J Gene Med; 2013 Jan; 15(1):20-7. PubMed ID: 23239404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
    Mobarra N; Shafiee A; Rad SM; Tasharrofi N; Soufi-Zomorod M; Hafizi M; Movahed M; Kouhkan F; Soleimani M
    In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):604-11. PubMed ID: 25672252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
    Sheikholeslami A; Nabiuni M; Arefian E
    Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.
    Loyer X; Potteaux S; Vion AC; Guérin CL; Boulkroun S; Rautou PE; Ramkhelawon B; Esposito B; Dalloz M; Paul JL; Julia P; Maccario J; Boulanger CM; Mallat Z; Tedgui A
    Circ Res; 2014 Jan; 114(3):434-43. PubMed ID: 24255059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-92a Regulates Expression of Kruppel-like Factor2 in Rabbit Model of Intracranial Aneurysm.
    Wu X; Zhang J; Huang Q; Yang P; Chen J; Liu J
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):44-8. PubMed ID: 26718427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA-205 affects infiltration and metastasis of breast cancer.
    Wang Z; Liao H; Deng Z; Yang P; Du N; Zhanng Y; Ren H
    Biochem Biophys Res Commun; 2013 Nov; 441(1):139-43. PubMed ID: 24129185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.